Literature DB >> 213384

Interstitial pneumonia and subclinical infection after intranasal inoculation of murine cytomegalovirus.

M C Jordan.   

Abstract

Although cytomegalovirus (CMV) infections are common throughout the world, little is known about the means of person-to-person transmission. To determine whether infection could be established by a respiratory route, studies were conducted in a murine CMV (MCMV) model by using intranasal inoculation. The infectious dose which resulted in pulmonary and systemic infection of half the mice was 100 plaque-forming units of MCMV. Here, infection was subclinical, but virus replicated in the lungs and subsequently disseminated via the blood to other organs within 7 days. The serum immunofluorescence antibody titer peaked by day 21. None of these mice died, although focal peribronchial interstitial pneumonitis was found in infected animals. In mice given greater than or equal to 10(4) plaque-forming units of MCMV intranasally, severe diffuse interstitial pneumonitis resulted uniformly, closely resembling that seen in immunocompromised patients and in newborn infants, and 20% of the animals died. Normal pulmonary architecture was obliterated by sheets of histiocytes, many containing MCMV intranuclear inclusions, and by accumulation of proteinaceous fluid in the interstitial and alveolar spaces. Of relevance to human disease, these experiments show that MCMV as a sole pathogen can cause severe interstitial pneumonitis in normal mice and that subclinical systemic infection results from respiratory inoculation of small amounts of virus.

Entities:  

Mesh:

Substances:

Year:  1978        PMID: 213384      PMCID: PMC421986          DOI: 10.1128/iai.21.1.275-280.1978

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  18 in total

1.  MOUSE CYTOMEGALOVIRUS INFECTION. II. OBSERVATIONS DURING PROLONGED INFECTIONS.

Authors:  D N MEDEARIS
Journal:  Am J Hyg       Date:  1964-07

2.  THE INCIDENCE OF INFECTION WITH CYTOMEGALOVIRUS IN A NORMAL POPULATION. A SEROLOGICAL STUDY IN GREATER LONDON.

Authors:  H STERN; S D ELEK
Journal:  J Hyg (Lond)       Date:  1965-03

3.  Mouse salivary gland virus infections.

Authors:  A MANNINI; D N MEDEARIS
Journal:  Am J Hyg       Date:  1961-05

4.  Reactivation of murine cytomegalovirus by cyclophosphamide.

Authors:  D R Mayo; J A Armstrong; M Ho
Journal:  Nature       Date:  1977-06-23       Impact factor: 49.962

5.  Immunosuppression reactivates and disseminates latent murine cytomegalovirus.

Authors:  M C Jordan; J D Shanley; J G Stevens
Journal:  J Gen Virol       Date:  1977-11       Impact factor: 3.891

6.  Pathogenesis of pulmonary cytomegalovirus infection in immunosuppressed mice.

Authors:  A R Brody; J E Craighead
Journal:  J Infect Dis       Date:  1974-06       Impact factor: 5.226

Review 7.  The cytomegaloviruses: ubiquitous agents with protean clinical manifestations. II.

Authors:  T H Weller
Journal:  N Engl J Med       Date:  1971-07-29       Impact factor: 91.245

8.  Pulmonary cytomegalovirus infection in the adult.

Authors:  J E Craighead
Journal:  Am J Pathol       Date:  1971-06       Impact factor: 4.307

9.  Detection of human salivary gland virus in the mouth and urine of children.

Authors:  W P ROWE; J W HARTLEY; H G CRAMBLETT; F M MASTROTA
Journal:  Am J Hyg       Date:  1958-01

10.  Role of macrophages in resistance to murine cytomegalovirus.

Authors:  M K Selgrade; J E Osborn
Journal:  Infect Immun       Date:  1974-12       Impact factor: 3.441

View more
  28 in total

Review 1.  The murine cytomegalovirus as a model for the study of viral pathogenesis and persistent infections.

Authors:  J B Hudson
Journal:  Arch Virol       Date:  1979       Impact factor: 2.574

Review 2.  Animal cytomegaloviruses.

Authors:  J Staczek
Journal:  Microbiol Rev       Date:  1990-09

3.  Comparison of serological tests for the detection of antibody to natural and experimental murine cytomegalovirus.

Authors:  G Lussier; D Guénette; J P Descôteaux
Journal:  Can J Vet Res       Date:  1987-04       Impact factor: 1.310

4.  Interstitial murine cytomegalovirus pneumonia after irradiation: characterization of cells that limit viral replication during established infection of the lungs.

Authors:  M J Reddehase; F Weiland; K Münch; S Jonjic; A Lüske; U H Koszinowski
Journal:  J Virol       Date:  1985-08       Impact factor: 5.103

5.  Virulence characteristics of murine cytomegalovirus in cell and organ cultures.

Authors:  M C Jordan; J L Takagi
Journal:  Infect Immun       Date:  1983-08       Impact factor: 3.441

6.  Alveolar Macrophages Are a Prominent but Nonessential Target for Murine Cytomegalovirus Infecting the Lungs.

Authors:  Helen E Farrell; Clara Lawler; Martha T Oliveira; Nick Davis-Poynter; Philip G Stevenson
Journal:  J Virol       Date:  2015-12-30       Impact factor: 5.103

7.  Replication of murine cytomegalovirus in lung macrophages: effect of phagocytosis of bacteria.

Authors:  J D Shanley; E L Pesanti
Journal:  Infect Immun       Date:  1980-09       Impact factor: 3.441

8.  Lungs are a major organ site of cytomegalovirus latency and recurrence.

Authors:  M Balthesen; M Messerle; M J Reddehase
Journal:  J Virol       Date:  1993-09       Impact factor: 5.103

9.  Specific history of heterologous virus infections determines anti-viral immunity and immunopathology in the lung.

Authors:  Hong D Chen; Armando E Fraire; Isabelle Joris; Raymond M Welsh; Liisa K Selin
Journal:  Am J Pathol       Date:  2003-10       Impact factor: 4.307

10.  Spontaneous activation of latent cytomegalovirus from murine spleen explants. Role of lymphocytes and macrophages in release and replication of virus.

Authors:  M C Jordan; V L Mar
Journal:  J Clin Invest       Date:  1982-10       Impact factor: 14.808

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.